US appeals court refuses Arzerra rehearing

17-07-2013

US appeals court refuses Arzerra rehearing

Biotechnology company Genmab A/S announced on July 15 that the US Court of Appeals for the Federal Circuit has refused a request to rehear a case related to its Arzerra product.


Genmab, GlaxoSmithKline, Genentech, Biogen, Arzerra

LSIPR